Possibilities of intervention in intrinsic and extrinsic lysis programs.
Lowe
G D
GD
University Department of Medicine, Royal Infirmary, Glasgow, United Kingdom.
D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D008019:Life Style; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D015849:Plasminogen Inactivators / Q000378:metabolism; D010959:Tissue Plasminogen Activator / Q000096:biosynthesis; D014568:Urokinase-Type Plasminogen Activator / Q000096:biosynthesis
D005343:Fibrinolytic Agents; D017395:Plasminogen Activator Inhibitor 1; D015849:Plasminogen Inactivators; D005340:Fibrinogen; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator